Shuqin Ni

机构：Shandong University of Traditional Chinese Medicine, Shandong Tumor Hospital, Shandong First Medical University · ORCID：0000-0003-4058-6184

发表论文 25 篇 · 总被引 110 次 · h-index 5

代表论文

• Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers (2017 · International Journal of Nanomedicine · 被引 34)
• Management of Subaxial Cervical Facet Dislocation Through Anterior Approach Monitored by Spinal Cord Evoked Potential (2013 · Spine · 被引 27)
• Interim results of a first-in-human phase 1 study of Q-1802, a CLDN18.2/PD-L1 bsABs, in patients with relapsed or refractory solid tumors. (2023 · Journal of Clinical Oncology · 被引 16)
• Severe open Lisfranc injuries: one-stage operation through internal fixation associated with vacuum sealing drainage (2016 · Journal of Orthopaedic Surgery and Research · 被引 16)
• Exogenous NT-3 Promotes Phenotype Switch of Resident Macrophages and Improves Sciatic Nerve Injury through AMPK/NF-κB Signaling Pathway (2024 · Neurochemical Research · 被引 5)
• Dexmedetomidine activates mitophagy and protects against pyroptosis in oxygen-glucose deprivation/reperfusion-induced brain damage via PINK1/Parkin pathway activation (2025 · Journal of Bioenergetics and Biomembranes · 被引 4)